Correlation Between Rhythm Pharmaceuticals and Uniqure NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rhythm Pharmaceuticals and Uniqure NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rhythm Pharmaceuticals and Uniqure NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rhythm Pharmaceuticals and Uniqure NV, you can compare the effects of market volatilities on Rhythm Pharmaceuticals and Uniqure NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rhythm Pharmaceuticals with a short position of Uniqure NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rhythm Pharmaceuticals and Uniqure NV.

Diversification Opportunities for Rhythm Pharmaceuticals and Uniqure NV

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Rhythm and Uniqure is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Rhythm Pharmaceuticals and Uniqure NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uniqure NV and Rhythm Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rhythm Pharmaceuticals are associated (or correlated) with Uniqure NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uniqure NV has no effect on the direction of Rhythm Pharmaceuticals i.e., Rhythm Pharmaceuticals and Uniqure NV go up and down completely randomly.

Pair Corralation between Rhythm Pharmaceuticals and Uniqure NV

Given the investment horizon of 90 days Rhythm Pharmaceuticals is expected to generate 0.66 times more return on investment than Uniqure NV. However, Rhythm Pharmaceuticals is 1.51 times less risky than Uniqure NV. It trades about 0.23 of its potential returns per unit of risk. Uniqure NV is currently generating about -0.05 per unit of risk. If you would invest  4,943  in Rhythm Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  1,049  from holding Rhythm Pharmaceuticals or generate 21.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Rhythm Pharmaceuticals  vs.  Uniqure NV

 Performance 
       Timeline  
Rhythm Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Rhythm Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Rhythm Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Uniqure NV 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Uniqure NV are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Uniqure NV may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Rhythm Pharmaceuticals and Uniqure NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rhythm Pharmaceuticals and Uniqure NV

The main advantage of trading using opposite Rhythm Pharmaceuticals and Uniqure NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rhythm Pharmaceuticals position performs unexpectedly, Uniqure NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uniqure NV will offset losses from the drop in Uniqure NV's long position.
The idea behind Rhythm Pharmaceuticals and Uniqure NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes